Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Schizophrenia
Recent news which mentions Schizophrenia
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
Tags
Contracts
Markets
Market News
From
Benzinga
Psychedelics And Schizophrenia: What's The Link?
February 19, 2023
Tags
Schizophrenia
Benzinga
Psychedelics
From
Benzinga
Tips on Managing Your Schizophrenia
August 22, 2022
Tickers
ALKS
Tags
Schizophrenia
NASDAQ:ALKS
NAMI
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise
June 08, 2022
Tickers
CBD
CURLF
Tags
Education
Market News
Markets
From
Benzinga
Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
April 06, 2022
Tickers
ADXN
Tags
Health Care
Penny Stocks
News
From
Benzinga
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial
February 24, 2022
Tickers
KRTX
Tags
General
Movers
Biotech
From
Benzinga
Cannabis Increases Odds Of This Disorder In Teens Despite Infrequent Use
February 08, 2022
Tags
Schizophrenia
mental health
Benzinga
From
Benzinga
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
February 08, 2022
Tickers
ALKS
Tags
Market News
ALKS
Health Care
From
Benzinga
Alkermes Highlights Signs and Symptoms of Schizophrenia
January 31, 2022
Tags
mental health
National Institute of Mental Health
Schizophrenia
From
3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial
January 10, 2022
Tickers
RVPH
Tags
Benzinga
Phase 3 Trial
Movers
From
Benzinga
FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders
December 01, 2021
Tickers
BTAI
Tags
Trading Ideas
Health Care
News
From
Benzinga
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
November 22, 2021
Tickers
NBIX
Tags
Market News
Contracts
Health Care
From
Benzinga
ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study
November 01, 2021
Tickers
ATAI
Tags
Phase 2 Trial
General
Benzinga
From
Benzinga
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
November 01, 2021
Tickers
TEVA
Tags
Market News
TEVA
Trading Ideas
From
Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
September 30, 2021
Tickers
NERV
Tags
General
Phase 2 Trial
NERV
From
Benzinga
Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program
September 13, 2021
Tickers
ALKS
Tags
Responsible Production & Consumption
opioid use disorder (OUD)
Sustainable Finance & Socially Responsible Investment
From
3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Approves First And Only Twice-Yearly Schizophrenia Drug
September 01, 2021
Tickers
JNJ
Tags
General
FDA
Market News
From
Benzinga
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
September 01, 2021
Tickers
TEVA
Tags
TEVA
Market News
General
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.